Garner, ME

Margaret Garner, Eastport, ME US

Patent application number	Description	Published
20090124683	MERCAPTAN AND SELENO-MERCAPTAN COMPOUNDS AND METHODS OF USING THEM - Novel mercaptan compounds, particularly those including a photolabile protecting group, are described as well as methods of using the compounds for the prevention and treatment of ocular damage and disease.	05-14-2009
20090192212	Dithiol Compounds, Derivatives, and Uses Therefor - Dithiol compounds and derivatives thereof are disclosed. The agents are useful for treating ocular disease, especially presbyopia and cataract.	07-30-2009
20100317608	Dithiol Compounds, Derivatives, and Uses Therefor - Dithiol compounds and derivatives thereof are disclosed. The agents are useful for treating ocular disease, especially presbyopia and cataract.	12-16-2010
20100317725	Choline Esters - Compounds, formulations, and methods are provided containing the choline ester of a reducing agent, especially lipoic acid or derivatives thereof. The compounds may be administered via a topical ocular route to treat or prevent oxidative damage.	12-16-2010

Patent application number	Description	Published
20090124683	MERCAPTAN AND SELENO-MERCAPTAN COMPOUNDS AND METHODS OF USING THEM - Novel mercaptan compounds, particularly those including a photolabile protecting group, are described as well as methods of using the compounds for the prevention and treatment of ocular damage and disease.	05-14-2009
20090192212	Dithiol Compounds, Derivatives, and Uses Therefor - Dithiol compounds and derivatives thereof are disclosed. The agents are useful for treating ocular disease, especially presbyopia and cataract.	07-30-2009
20100317608	Dithiol Compounds, Derivatives, and Uses Therefor - Dithiol compounds and derivatives thereof are disclosed. The agents are useful for treating ocular disease, especially presbyopia and cataract.	12-16-2010
20100317725	Choline Esters - Compounds, formulations, and methods are provided containing the choline ester of a reducing agent, especially lipoic acid or derivatives thereof. The compounds may be administered via a topical ocular route to treat or prevent oxidative damage.	12-16-2010

Patent application number	Description	Published
20090258955	INTRAOCULAR IRRIGATING SOLUTION HAVING IMPROVED FLOW CHARACTERISTICS - Improved intraocular irrigating solutions are described comprising a cellulose derivative such as hydroxypropylmethylcellulose. In addition, certain solutions of the present invention comprise glutathione and dextrose. The solutions have enhanced viscosities that reduce the risk of damage to intraocular tissues during intraocular surgical procedures by reducing the turbulence of the solutions and dampening the movement of tissue fragments and air bubbles. The solutions preferably also have modified surface tensions that more closely resemble the surface tension of the aqueous humor.	10-15-2009